Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
This early phase I trial studies the side effects of personalized vaccine in treating
patients with smoldering multiple myeloma. Vaccines made from a person's blood and bone
marrow may help the body build an effective immune response to kill cancer cells.